ATOGEN
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $5.2M
Investors
- 5
About ATOGEN
, Ltd. operates as a biotechnology company that focuses on the development of new drugs and food materials to improve health. ATOGEN provides functional probiotics products such as HAC01 analyses the body fat loss and blood glucose reduction activities, ATG-K2 analyses the effect of body fat and fatty liver, ATG-K8, ATG-F4 enhance muscle function and dopamine secretion, ATG-F5 improve wrinkle formation, acne, whitening, etc.
Who invested in ATOGEN
5 investors across 1 round
See all investors in ATOGEN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 15, 2020
Amount
$5.2M
Investors
Questions about ATOGEN
Who invested in ATOGEN?
ATOGEN has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ATOGEN raised?
ATOGEN has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ATOGEN last raise money?
ATOGEN's most recent round on record is a Series A, in Jan 2020.
What does ATOGEN do?
ATOGEN is a biotechnology company.
Where is ATOGEN headquartered?
ATOGEN is headquartered in South Korea.
Which VCs invest in companies like ATOGEN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ATOGEN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ATOGEN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.